The synthesis and optimization of the anti-Helicobacter pylori activity of
a novel series of benzyloxyisoquinoline derivatives that was discovered by
a random screening process, are described. In the in vitro assay, compound
10c containing a 3-acetamido-2,6-dichlorobenzyl substituent was found to ha
ve extremely potent activity against H. pylori and no activity against othe
r common bacteria. The anti-H. pylori activity of 10c was superior to that
of amoxicillin (AMPC) (1) and clarithromycin (CAM) (2), However, 10c did no
t show in vivo efficacy in a mouse infection model; a feature attributed to
the lack of strong bactericidal activity at short contact times. (C) 1999
Elsevier Science Ltd. All rights reserved.